Saltar al contenido
Merck
Todas las fotos(1)

Key Documents

View All Documentation

1612608

USP

Silver sulfadiazine

United States Pharmacopeia (USP) Reference Standard

Sinónimos:

Silver(I) sulfadiazine, Sulfadiazine silver

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):
C10H9AgN4O2S
Número de CAS:
22199-08-2
Peso molecular:
357.14
Número MDL:
MFCD00072101
Código UNSPSC:
41116107
ID de la sustancia en PubChem:
329751096
NACRES:
NA.24

grado

pharmaceutical primary standard

familia API

sulfadiazine

fabricante / nombre comercial

USP

mp

285 °C (dec.) (lit.)

aplicaciones

pharmaceutical (small molecule)

formato

neat

cadena SMILES

Nc1ccc(cc1)S(=O)(=O)N([Ag])c2ncccn2

InChI

1S/C10H9N4O2S.Ag/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1

Clave InChI

UEJSSZHHYBHCEL-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

Categorías relacionadas

Descripción general

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicación

Silver sulfadiazine USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
  • Silver Sulfadiazine Cream

Nota de análisis

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Otras notas

Sales restrictions may apply.

Producto relacionado

Referencia del producto
Descripción
Precios

1625009

Sulfadiazine, United States Pharmacopeia (USP) Reference Standard

1633506

Ácido sulfanílico, United States Pharmacopeia (USP) Reference Standard

PHR1343

Sulfadiazine, Pharmaceutical Secondary Standard; Certified Reference Material

S1800000

Sulfadiazine, European Pharmacopoeia (EP) Reference Standard

Y0001469

Sulfadiazine impurity A, European Pharmacopoeia (EP) Reference Standard

Y0001480

Sulfadiazine, European Pharmacopoeia (EP) Reference Standard

Y0001462

Acetylsulfadiazine, European Pharmacopoeia (EP) Reference Standard

PHR1419

Ácido sulfanílico, Pharmaceutical Secondary Standard; Certified Reference Material

BP312

Sulfadiazine, British Pharmacopoeia (BP) Reference Standard

Código de clase de almacenamiento

11 - Combustible Solids

Clase de riesgo para el agua (WGK)

WGK 2

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

F W Fuller et al.
The Journal of burn care & rehabilitation, 15(3), 213-223 (1994-05-01)
A review of the periodical literature relating to burn topical antibacterial agents as listed in the Cumulated Index Medicus from January 1, 1965, through November 30, 1992, as well as bound volumes and unpublished material reveals that the optimal dose
Diagnostic challenges of assessing the depth of burn injuries overlying intricate coloured tattoos.
U Sarwar et al.
Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 67(7), e186-e187 (2014-02-25)
Andrew C Miller et al.
Journal of the American Academy of Dermatology, 66(5), e159-e165 (2010-08-21)
For decades silver-containing antibiotics such as silver sulfadiazine (SSD) have been applied as standard topical therapy for patients with partial-thickness burns and venous stasis ulcers. This evidence-based review intends to answer the following research question: in ambulatory patients with partial-thickness
M Prosdocimi et al.
Minerva medica, 103(6), 533-539 (2012-12-12)
Diabetes-related chronic cutaneous lesions are a serious and common problem, as well as a major cause for hospital admissions, although no general consensus has been reached on the best available treatment for this frequent pathological condition. The primary objective of
Frederick W Fuller
Journal of burn care & research : official publication of the American Burn Association, 30(3), 464-470 (2009-04-08)
Silver sulfadiazine cream has an enviable safety record in burn treatment. However, it side effects, exemplified by allergic reactions to its sulfadiazine moiety, silver staining of the treated burn wound, hyperosmolality, methemoglobinemia, and hemolysis due to a congential lack of
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico